Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:27 pm Purchase | 2024-09-30 | 13G | SAGIMET BIOSCIENCES INC SER A SGMT | BAKER BROS. ADVISORS LP | 1,538,489 4.990% | 81,971 (+5.63%) | Filing History |
| 2024-11-14 4:26 pm Purchase | 2024-09-30 | 13G | CELCUITY INC CELC | BAKER BROS. ADVISORS LP | 1,874,978 5.100% | 1,874,978 (New Position) | Filing History |
| 2024-11-14 4:24 pm Purchase | 2024-09-30 | 13G | STOKE THERAPEUTICS INC STOK | BAKER BROS. ADVISORS LP | 4,368,443 8.300% | 4,368,443 (New Position) | Filing History |
| 2024-11-14 4:23 pm Sale | 2024-09-30 | 13G | ACHILLES THERAPEUTICS PLC ACHL | BAKER BROS. ADVISORS LP | 0 0.000% | -3,311,567 (Position Closed) | Filing History |
| 2024-11-14 4:21 pm Purchase | 2024-09-30 | 13G | NURIX THERAPEUTICS INC NRIX | BAKER BROS. ADVISORS LP | 6,751,565 9.700% | 1,799,113 (+36.33%) | Filing History |
| 2024-11-14 4:21 pm Sale | 2024-09-30 | 13G | AEROVATE THERAPEUTICS INC AVTE | BAKER BROS. ADVISORS LP | 17,970 2.200% | -30,045 (-62.57%) | Filing History |
| 2024-11-14 4:20 pm Purchase | 2024-09-30 | 13G | REPLIMUNE GROUP INC REPL | BAKER BROS. ADVISORS LP | 11,045,336 16.200% | 1,500,000 (+15.71%) | Filing History |
| 2024-11-14 4:17 pm Sale | 2024-09-30 | 13G | ATHIRA PHARMA INC ATHA | BAKER BROS. ADVISORS LP | 0 0.000% | -315,381 (Position Closed) | Filing History |
| 2024-11-14 4:14 pm Purchase | 2024-09-30 | 13G | EDGEWISE THERAPEUTICS INC EWTX | BAKER BROS. ADVISORS LP | 5,840,059 6.200% | 5,840,059 (New Position) | Filing History |
| 2024-11-14 4:11 pm Purchase | 2024-09-30 | 13G | ABCELLERA BIOLOGICS INC. ABCL | BAKER BROS. ADVISORS LP | 27,525,640 9.300% | 4,615,887 (+20.15%) | Filing History |
| 2024-10-10 5:01 pm Purchase | 2024-10-08 | 13D | TALIS BIOMEDICAL CORP COM TLIS | BAKER BROS. ADVISORS LP | 2,507,193 65.600% | 2,107 (+0.08%) | Filing History |
| 2024-10-08 5:29 pm Purchase | 2024-10-04 | 13D | KINIKSA PHARMACEUTICALS INTL P KNSA | BAKER BROS. ADVISORS LP | 3,151,029 7.700% | 247,999 (+8.54%) | Filing History |
| 2024-08-22 4:15 pm Purchase | 2024-08-21 | 13D | KYMERA THERAPEUTICS INC KYMR | BAKER BROS. ADVISORS LP | 6,001,262 9.300% | 3,556 (+0.06%) | Filing History |
| 2024-06-28 4:11 pm Purchase | 2024-06-26 | 13D | KALA BIO, INC. KALA | BAKER BROS. ADVISORS LP | 17,827 19.990% | 12,443 (+231.11%) | Filing History |
| 2024-06-26 4:54 pm Purchase | 2024-06-24 | 13D | ENTRADA THERAPEUTICS INC TRDA | BAKER BROS. ADVISORS LP | 4,865,819 13.200% | 161,400 (+3.43%) | Filing History |
| 2024-06-14 6:52 pm Purchase | 2024-06-14 | 13D | HOOKIPA PHARMA INC HOOK | BAKER BROS. ADVISORS LP | 981,315 9.990% | 166,416 (+20.42%) | Filing History |
| 2024-06-14 6:23 pm Sale | 2024-06-12 | 13D | INCYTE CORPORATION INCY | BAKER BROS. ADVISORS LP | 31,209,896 16.300% | -5,459,183 (-14.89%) | Filing History |
| 2024-05-28 4:16 pm Purchase | 2024-05-23 | 13D | BICYCLE THERAPEUTICS PLC SPONS BCYC | BAKER BROS. ADVISORS LP | 9,399,960 19.900% | 1,710,717 (+22.25%) | Filing History |
| 2024-05-13 6:06 pm Unchanged | 2024-05-12 | 13D | INCYTE CORPORATION INCY | BAKER BROS. ADVISORS LP | 36,669,079 16.300% | 0 (Unchanged) | Filing History |
| 2024-05-09 6:40 pm Purchase | 2024-05-07 | 13D | INCYTE CORPORATION INCY | BAKER BROS. ADVISORS LP | 36,669,079 16.300% | 27,617 (+0.08%) | Filing History |